Texas Children's’s AbbVie ABBV Stock Holding History

Texas Children's’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-476	Closed	-$44K	–	26
2018 Q4	$44K	Buy	+476	New	+$41.9K	0.06%	31

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Texas Children's's ABBV Position: Q1 2019 in Review

Texas Children's sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 476 shares — an estimated $44K sold.

Texas Children's first reported a position in ABBV in Q4 2018 and held it in 1 quarter. The position peaked at $44K in Q4 2018. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Texas Children's reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
Texas Children's sold 476 AbbVie shares in Q1 2019, an estimated $44K.
Texas Children's first reported a position in AbbVie in Q4 2018 and held it in 1 quarter.
Texas Children's's AbbVie position peaked at $44K in Q4 2018.
2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Texas Children's's 13F filing for Q1 2019, filed 14 May 2019.